Eisai to Launch “Pariet S,” the First Proton Pump Inhibitor RX-to-OTC in Japan
TOKYO, June 2, 2025 – (JCN Newswire) – Eisai Co., Ltd. announced today the launch of “Pariet®S” (pharmaceutical requiring guidance), which is highly effective in alleviating severe heartburn andstomach pain caused by gastric acid reflux, at pharmacies and drugstores throughout Japan.(1)”Pariet S” is the first proton pump inhibitor (PPI(2)) to receive manufacturing and marketing approval
TOKYO, June 2, 2025 – (JCN Newswire) – Eisai Co., Ltd. announced today the launch of “Pariet®S” (pharmaceutical requiring guidance), which is highly effective in alleviating severe heartburn andstomach pain caused by gastric acid reflux, at pharmacies and drugstores throughout Japan.(1)”Pariet S” is the first proton pump inhibitor (PPI(2)) to receive manufacturing and marketing approval as an over the counter (OTC) medicine in Japan…
Read More
About Author
